Occupational Therapists in Kamuela, HI Accepting Medicare
4 Occupational Therapists found. Showing 1 - 4
 June Kaniho, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 64-974 Mamalahoa Hwy, Kamuela, HI 96743 Phone: 808-885-4551 |
 Keiki Therapy Llc Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 64-957 Mamalahoa Hwy, Kamuela, HI 96743 Phone: 808-209-7934 Fax: 808-883-6262 |
Chanda Zavodny, OTR Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 64-957 Mamalahoa Hwy, Kamuela, HI 96743 Phone: 321-537-0067 |
Nicole M Koranda, OTRL Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 64-957 Mamalahoa Hwy, Kamuela, HI 96743 Phone: 808-209-7934 Fax: 808-883-6262 |
News Archive
People living with HIV in Egypt feel health care sector is source of stigma, report says
According to a 2011 report on HIV-related stigma in Egypt from the Egyptian Initiative for Personal Rights, "the health care sector was consistently identified by people living with HIV as a major source of stigma and discrimination," PlusNews reports.
YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
FDA assigns priority review to ATryn from GTC Biotherapeutics
The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s Biologic License Application, or BLA, for ATryn.
Getting older increases Americans' risk of death from excessive BMI
Obesity kills, giving rise to a host of fatal diseases. This much is well known. But when it comes to seniors, a slew of prominent research has reported an "obesity paradox" that says, at age 65 and older, having an elevated BMI won't shorten your lifespan, and may even extend it. A new study takes another look at the numbers, finding the earlier research flawed.
› Verified 5 days ago
Chiropractors
Physical Therapists
Optometrists
Occupational Therapists
Speech-Language Pathologists